Strategic Design Services for Biotechnology Firm Abeome
Abeome Corporation is an innovative biotechnology company engaging in the development of therapeutic and diagnostic monoclonal antibodies for life sciences and clinical medicine areas.
Based in Athens, Georgia, Abeome has developed and patented novel technology for the rapid discovery of high quality monoclonal antibodies, and manufactures kits and specialized growth media to allow researchers to use that technology in their own laboratories.
Bynder Group was originally engaged with helping Abeome transition into a new brand and positioning platform to attract strategic partners and investors. We continue to advise as Abeome ramps up antibody commercialization with rapid growth.